Finance

Lists
Why is 300725 down 3,10%?
Dive Deeper
300725:SHE
PharmaBlock Sciences Nanjing Inc
CN¥44,03
-3,10%
(-1,41) 1D
16 Okt., 15:04:10 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300725...
Open
CN¥46,61
High
CN¥48,98
Low
CN¥43,30
Mkt. cap
10,62 mjd
Avg. vol.
20,20 m
Volume
28,03 m
Dividend
0,55%
Quarterly dividend
CN¥0,06
Ex-dividend date
25 Aug. 2026
P/E ratio
47,31
52-wk high
CN¥57,55
52-wk low
CN¥30,90
EPS
CN¥0,93
Shares outstanding
233,81 m
No. of employees
3 k
Open
CN¥46,61
High
CN¥48,98
Low
CN¥43,30
Mkt. cap
10,62 mjd
Avg. vol.
20,20 m
Volume
28,03 m
Dividend
0,55%
Quarterly dividend
CN¥0,06
Ex-dividend date
25 Aug. 2026
P/E ratio
47,31
52-wk high
CN¥57,55
52-wk low
CN¥30,90
EPS
CN¥0,93
Shares outstanding
233,81 m
No. of employees
3 k
News stories
From web sources and news partners
About PharmaBlock Sciences Nanjing Inc
CEO-
Employees2,59 k
Founded26 Des. 2006
Headquarters-
SectorPharmaceutical industry
Websitepharmablock.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
499,33 m
555,42 m
508,03 m
551,43 m
Cost of goods sold
310,52 m
416,74 m
344,74 m
391,71 m
Cost of revenue
310,52 m
416,74 m
344,74 m
391,71 m
Research and development expenses
30,69 m
29,67 m
29,81 m
30,87 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,35 m
64,04 m
65,83 m
75,78 m
Operating expense
94,22 m
128,61 m
96,71 m
109,23 m
Total operating expenses
404,74 m
545,35 m
441,46 m
500,94 m
Operating income
94,59 m
10,07 m
66,58 m
50,48 m
Other non operating income
-849,10 k
623,93 k
-12,44 m
11,16 m
EBT including unusual items
41,96 m
79,37 m
52,80 m
61,00 m
EBT excluding unusual items
96,04 m
20,50 m
61,83 m
45,99 m
Income tax expense
1,07 m
9,03 m
3,91 m
10,44 m
Effective tax rate
2,55%
11,38%
7,41%
17,12%
Other operating expenses
-1,99 m
9,24 m
-1,41 m
5,91 m
Net income
40,89 m
70,34 m
48,89 m
50,56 m
Net profit margin
8,19%
12,67%
9,62%
9,17%
Earnings per share
-
-
-
-
Interest and investment income
12,13 m
13,93 m
8,31 m
7,28 m
Interest expense
-9,86 m
-
-618,48 k
-649,04 k
Net interest expenses
2,28 m
13,93 m
7,69 m
6,64 m
Depreciation and amortization charges
-
-
-
-
EBITDA
126,78 m
43,77 m
100,27 m
86,65 m
Gain or loss from assets sale
-
-1,15 m
-
-84,72 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme